ABG
RETA

Ally Bridge Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Ally Bridge Group’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-105,558
Closed -$10.8M – 25
2023
Q2 		$10.8M Buy
+105,558
New +$10.8M 13.04% 1